Natriuretic peptide hormone measurement in acute coronary syndromes.
Cardiac Ischemia is an important trigger for the release of B-type natriuretic peptide (BNP). BNP and N-terminal pro-BNP (N-proBNP) are emerging as important biomarkers for risk stratification in patients with acute coronary syndromes. Higher levels of BNP and pro-BNP are associated with a greater risk for death and heart failure, independent of traditional clinical variables and levels of other biomarkers such as troponins and C-reactive protein. The therapeutic implications of these findings are not yet known.
Maewal
Param
P
Donald W. Reynolds Cardiovascular Clinical Research Center and Department of Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
de Lemos
James A
JA
D000208:Acute Disease; D001681:Biological Assay; D015415:Biomarkers / Q000032:analysis; D003327:Coronary Disease / Q000175:diagnosis*; D006333:Heart Failure / Q000175:diagnosis; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis; D017202:Myocardial Ischemia / Q000175:diagnosis; D020097:Natriuretic Peptide, Brain / Q000032:analysis*; D011379:Prognosis; D018570:Risk Assessment
D015415:Biomarkers; D020097:Natriuretic Peptide, Brain